All Reviews
Independent, evidence-based reviews. Each score reflects the published research, supplier transparency and regulatory clarity at the time of last review.
Primary research interestMetabolic outcomes & incretin pathway analysis
Next-generation triple hormone receptor agonist showing exceptional potential for weight loss and metabolic improvement.
Primary research interestGrowth hormone axis & body composition research
Powerful GH secretagogue combination researched for recovery, sleep quality and body composition.
Primary research interestMetabolic outcomes & incretin pathway analysis
Dual GIP/GLP-1 receptor agonist with strong trial evidence for type 2 diabetes and weight management.
Primary research interestTissue repair & recovery research
Broad healing peptide researched for tissue repair, injury recovery and gut health support.
Primary research interestTissue repair & recovery research
Supports tissue repair, reduces inflammation and improves recovery time in research models.
Primary research interestGHRH-axis pulsatile release research
GHRH analog studied and approved in some jurisdictions for HIV-related lipodystrophy.
Primary research interestGrowth hormone axis & body composition research
Modified GRF analog paired with ipamorelin for synergistic GH release in research.
Primary research interestMetabolic outcomes & incretin pathway analysis
Widely-prescribed GLP-1 receptor agonist with substantial trial evidence for weight loss and type 2 diabetes.
Primary research interestSelective GH release & sleep architecture research
Selective GH secretagogue with a relatively clean side-effect profile in research literature.
Primary research interestGHRH-axis pulsatile release research
Long-acting GHRH analog often combined with GH secretagogues in research models.
Primary research interestMetabolic outcomes & incretin pathway analysis
GLP-1 receptor agonist approved for type 2 diabetes and weight management.
Primary research interestGHRH-axis pulsatile release research
Short-acting GHRH analog with a long history of clinical use.
Primary research interestDermal collagen synthesis & wound-healing research
Copper tripeptide widely studied for skin and wound healing applications.
Primary research interestImmune-modulation & inflammation research
Immune-modulating peptide approved in some jurisdictions for hepatitis B and other indications.
Primary research interestGHRH-axis pulsatile release research
Short-acting GHRH analog with natural pulsatile-mimicking properties, often combined with GH secretagogues.
Primary research interestCellular ageing & mitochondrial research
Mitochondrial-derived peptide studied for metabolic and longevity pathways.
Primary research interestSelective GH release & sleep architecture research
Non-peptide GH secretagogue and ghrelin mimetic studied for muscle growth and recovery.
Primary research interestCognitive performance & neuroprotection research
Peptide-enriched brain extract studied and used clinically for cognitive and neurological indications.
Primary research interestTissue repair & recovery research
Cosmetic and recovery peptide stack combining collagen support, tissue repair and inflammation modulation.
Primary research interestDermal collagen synthesis & wound-healing research
Palmitoyl pentapeptide studied for collagen synthesis stimulation in topical cosmetic applications.
Primary research interestDermal collagen synthesis & wound-healing research
Copper-binding peptides studied for collagen synthesis, wound healing and antioxidant effects in research.
Primary research interestMetabolic outcomes & incretin pathway analysis
Triple monoamine reuptake inhibitor investigated for weight loss through appetite and energy effects.
Primary research interestMetabolic outcomes & incretin pathway analysis
GH fragment originally developed for fat loss; mixed clinical evidence.
Primary research interestImmune-modulation & inflammation research
Tripeptide studied for anti-inflammatory pathways in research models.
Primary research interestCognitive performance & neuroprotection research
Russian-origin synthetic peptide studied for anxiolytic and cognitive effects.
Primary research interestSelective GH release & sleep architecture research
Potent GH secretagogue studied for muscle growth, but with reported cortisol elevation.
Primary research interestSelective GH release & sleep architecture research
Potent growth hormone-releasing peptide investigated for GH elevation in research models.
Primary research interestCellular ageing & mitochondrial research
Mitochondrial-targeting tetrapeptide studied for cellular energy metabolism and cardioprotection.
Primary research interestCosmetic biology & topical research
Hexapeptide investigated for dynamic wrinkle reduction through acetylcholine signaling modulation.
Primary research interestImmune-modulation & inflammation research
Tight-junction modulator studied for intestinal barrier function in coeliac disease and inflammatory conditions.
Primary research interestSelective GH release & sleep architecture research
Early GH secretagogue investigated for growth hormone release with appetite-related effects.
Primary research interestSexual function & melanocortin pathway research
Bremelanotide — a melanocortin receptor agonist approved in some jurisdictions for sexual dysfunction.
Primary research interestCellular ageing & mitochondrial research
Tetrapeptide studied in longevity literature with modest evidence base.
Primary research interestMetabolic outcomes & incretin pathway analysis
C-terminal GH fragment studied for lipolytic effects in research models.
Primary research interestGrowth hormone axis & body composition research
Long-acting IGF-1 analog studied for muscle growth and recovery in research.
Primary research interestCognitive performance & neuroprotection research
Russian-origin synthetic peptide studied for cognitive and neuroprotective effects.
Primary research interestCosmetic biology & topical research
Acetylated octapeptide studied for wrinkle reduction through SNARE complex modulation in research.
Primary research interestDermal collagen synthesis & wound-healing research
Lipid-conjugated peptides studied for skin and wound-healing applications with enhanced membrane penetration.
Primary research interestSleep architecture & circadian research
Delta-sleep-inducing peptide with a long research history but limited modern human evidence.
Primary research interestTissue repair & recovery research
Myostatin inhibitor studied for muscle growth by blocking myostatin signalling.
Primary research interestCognitive performance & neuroprotection research
Tripeptide studied for pineal gland function and neuroprotection in research.
Primary research interestCognitive performance & neuroprotection research
Extended-chain variant of Semax investigated for enhanced neuroprotective effects.
Primary research interestGrowth hormone axis & body composition research
IGF-1 variant lacking the D-domain studied for tissue anabolism with reduced mitogenic signalling.
Primary research interestCognitive performance & neuroprotection research
Neurotropic peptide studied for cognitive and neuroprotective effects through Akt and ERK signalling.
Primary research interestCellular ageing & mitochondrial research
Interfering peptide targeting FOXO4 investigated for senescent cell clearance in research.
Primary research interestCognitive performance & neuroprotection research
Tripeptide investigated for cognitive and stress-resilience effects in research models.
Primary research interestCognitive performance & neuroprotection research
Dipeptide studied for neuroprotection and cognitive effects in research models.
Primary research interestMetabolic outcomes & incretin pathway analysis
Peptide targeted to adipose tissue investigated for weight loss through apoptosis.
Primary research interestCosmetic biology & topical research
Melanocortin-1 receptor agonist studied for pigmentation effects; limited modern research.
Primary research interestCosmetic biology & topical research
Synthetic melanocortin analog with significant safety concerns.